129 related articles for article (PubMed ID: 9871443)
1. Direct and indirect presynaptic control of dopamine release by excitatory amino acids.
Chéramy A; L'hirondel M; Godeheu G; Artaud F; Glowinski J
Amino Acids; 1998; 14(1-3):63-8. PubMed ID: 9871443
[TBL] [Abstract][Full Text] [Related]
2. Contribution of endogenously formed arachidonic acid in the presynaptic facilitatory effects of NMDA and carbachol on dopamine release in the mouse striatum.
L'hirondel M; Chéramy A; Artaud F; Godeheu G; Glowinski J
Eur J Neurosci; 1999 Apr; 11(4):1292-300. PubMed ID: 10103124
[TBL] [Abstract][Full Text] [Related]
3. Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes.
Desce JM; Godeheu G; Galli T; Glowinski J; Chéramy A
Brain Res; 1994 Mar; 640(1-2):205-14. PubMed ID: 7911726
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes.
Chéramy A; Desce JM; Godeheu G; Glowinski J
Neurochem Int; 1994 Aug; 25(2):145-54. PubMed ID: 7994195
[TBL] [Abstract][Full Text] [Related]
5. Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum.
Chéramy A; Godeheu G; L'Hirondel M; Glowinski J
J Pharmacol Exp Ther; 1996 Feb; 276(2):616-25. PubMed ID: 8632329
[TBL] [Abstract][Full Text] [Related]
6. Homeostatic regulation of excitatory synapses on striatal medium spiny neurons expressing the D2 dopamine receptor.
Thibault D; Giguère N; Loustalot F; Bourque MJ; Ducrot C; El Mestikawy S; Trudeau LÉ
Brain Struct Funct; 2016 May; 221(4):2093-107. PubMed ID: 25782435
[TBL] [Abstract][Full Text] [Related]
7. Role of arachidonic acid in the regulation of the NMDA-evoked release of acetylcholine in striatal compartments.
Blanchet F; Gauchy C; Perez S; Glowinski J; Kemel ML
Synapse; 1999 Feb; 31(2):140-50. PubMed ID: 10024011
[TBL] [Abstract][Full Text] [Related]
8. L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors.
Desce JM; Godeheu G; Galli T; Artaud F; Chéramy A; Glowinski J
Neuroscience; 1992; 47(2):333-9. PubMed ID: 1379352
[TBL] [Abstract][Full Text] [Related]
9. Role of excitatory amino acids in the direct and indirect presynaptic regulation of dopamine release from nerve terminals of nigrostriatal dopaminergic neurons.
Cheramy A; Kemel ML; Gauchy C; Desce JM; Galli T; Barbeito L; Glowinski J
Amino Acids; 1991 Oct; 1(3):351-63. PubMed ID: 24194175
[TBL] [Abstract][Full Text] [Related]
10. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
Lavoute C; Weiss M; Rostain JC
Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
[TBL] [Abstract][Full Text] [Related]
11. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals.
Krebs MO; Desce JM; Kemel ML; Gauchy C; Godeheu G; Cheramy A; Glowinski J
J Neurochem; 1991 Jan; 56(1):81-5. PubMed ID: 1824785
[TBL] [Abstract][Full Text] [Related]
12. Effects of volatile anesthetics, thiopental, and ketamine on spontaneous and depolarization-evoked dopamine release from striatal synaptosomes in the rat.
Mantz J; Varlet C; Lecharny JB; Henzel D; Lenot P; Desmonts JM
Anesthesiology; 1994 Feb; 80(2):352-63. PubMed ID: 8311317
[TBL] [Abstract][Full Text] [Related]
13. NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role.
Kendrick KM; Guevara-Guzman R; de la Riva C; Christensen J; Ostergaard K; Emson PC
Eur J Neurosci; 1996 Dec; 8(12):2619-34. PubMed ID: 8996812
[TBL] [Abstract][Full Text] [Related]
14. The role of N-methyl-D-aspartate receptors and nitric oxide in cochlear dopamine release.
Halmos G; Horváth T; Polony G; Fekete A; Kittel A; Vizi ES; van der Laan BF; Zelles T; Lendvai B
Neuroscience; 2008 Jun; 154(2):796-803. PubMed ID: 18462886
[TBL] [Abstract][Full Text] [Related]
15. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.
Campos F; Alfonso M; Vidal L; Faro LR; Durán R
Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020
[TBL] [Abstract][Full Text] [Related]
16. Role of NMDA, AMPA and kainate receptors in mediating glutamate- and 4-AP-induced dopamine and acetylcholine release from rat striatal slices.
Jin S; Fredholm BB
Neuropharmacology; 1994 Sep; 33(9):1039-48. PubMed ID: 7838316
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine: involvement of both NMDA and AMPA/kainate subtypes.
Ohta K; Araki N; Shibata M; Komatsumoto S; Shimazu K; Fukuuchi Y
Neurosci Res; 1994 Nov; 21(1):83-9. PubMed ID: 7535906
[TBL] [Abstract][Full Text] [Related]
19. Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release.
Risso F; Parodi M; Grilli M; Molfino F; Raiteri M; Marchi M
Neurochem Int; 2004 Apr; 44(5):293-301. PubMed ID: 14643746
[TBL] [Abstract][Full Text] [Related]
20. Modulation of striatal dopamine release by glycine transport inhibitors.
Javitt DC; Hashim A; Sershen H
Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
